Intel Plunges 7% as UBS Slashes Price Target to $112

Intel shares plunged 7% as UBS cut its price target to $112, adding pressure to a semiconductor stock already navigating a challenging competitive position against NVIDIA in AI accelerators and AMD in server processors. The UBS price target reduction signals ongoing analyst uncertainty about Intel's ability to execute its foundry strategy and regain process technology leadership after falling behind Taiwan Semiconductor and Samsung in advanced node competition.

The 7% single-session decline reflects compounding concerns: the broader bond market shock hitting growth and technology stocks on Tuesday, combined with Intel-specific headwinds from UBS's revised target. Intel's roadmap to 18A process node, which management has positioned as the pivotal competitive response to TSMC's N3 generation, has faced skepticism from institutional investors who have seen previous Intel technology milestones delayed. The mention of NVIDIA's ticker alongside Intel in the GuruFocus coverage suggests the AI chip competitive landscape is the analytical frame driving the price target revision.

For semiconductor sector investors, Intel's continued underperformance relative to NVIDIA and AMD raises questions about the long-term structure of the AI chip supply chain. Intel's dual bet on being both a chip designer and a contract foundry has yet to produce the revenue synergies management projected, while its core x86 data centre business continues to lose workloads to ARM-based alternatives. UBS's $112 target implies modest upside from current levels, which institutional investors may read as a tacit acknowledgement that the recovery thesis requires patience measured in years rather than quarters.

• Intel stock plunges 7% as UBS cuts price target to $112 amid foundry and AI chip concerns
• Bond market shock compounds Intel-specific headwinds from analyst price target reduction
• Intel's dual designer-foundry strategy under continued scrutiny as NVIDIA and AMD gain share